The year 2015 will witness initial public offerings (IPOs) of state-owned companies as well as privately held ones. We forecast the latter will take place during the first half of the year, whereas state-owned companies have yet to meet internal requirements, notably approval by their relevant governance bodies. This includes finalising the terms of the listing, such as...
Algeria
Displaying 115 - 120 of 198
Interviews & Viewpoints | OBG talks to Samy Laghouati, Partner, Gide Loyrette Nouel from The Report: Algeria 2014
Interviews & Viewpoints | OGB talks to Abdelhak Lamiri, President, Groupe INSIM from The Report: Algeria 2014
Interviews & Viewpoints | Samir Hadj Ali, Chartered Accountant and Managing Partner, Mazars, on encouraging research and development from The Report: Algeria 2014
Algeria has in its tax law attractive incentives to enhance research and development (R&D), such as allowing for the deduction of operating expenses incurred for scientific or technical research in the year in which these expenses were incurred. An additional incentive is for companies to deduct expenses incurred within the framework of R&D within a limit of 10%...
Interviews & Viewpoints | OBG talks to Yiğit Gürçay, Senior Vice-President and Area Director – MENA, GlaxoSmithKline from The Report: Algeria 2014
What benefits can multinational pharmaceutical companies derive from expanding local production activities in emerging markets?
